Skip to content
SmartFigure
Aditya Birla Sun Life Mutual Fund

Aditya Birla Sun Life Pharma and Healthcare Fund

Aditya Birla Sun Life Mutual Fund · Direct plan · Growth

3-year returns
21.6%
a year
NAV
₹40.80
▲ 1.09% · 18 Sept 2026
Fund size
₹1,103 Cr
Expense ratio
0.8%
a year
Minimum SIP
₹100

Figures are for the Direct plan. The Regular plan, bought through a distributor, is at ₹36.60 and has returned 19.96% a year over 3 years.

Returns, and where it stands

Against the average sectoral / thematic fund, and its place among them. Anything longer than a year is a yearly rate.

PeriodThis fundCategoryRank
1 year17.6%5.2%ahead23 of 221
3 years21.6%14.5%ahead14 of 136
5 years14.5%12.9%ahead35 of 98
Every period, and the Regular plan →
PeriodDirectRegular
1 month0.1%0%
3 months9.3%9%
6 months19.5%18.8%
1 year17.6%16%
2 yearsp.a.8.5%7.1%
3 yearsp.a.21.6%20%
5 yearsp.a.14.5%12.9%
7 yearsp.a.21.7%19.9%

Figures are for the Direct plan, and the rank compares it against the same plan of its peers, best first. Based on NAV history from Jul 2019.

Plan

NAV history

▲ 17.58% in the last 1Y

32.536.841.118 Sept 202520 Mar 202618 Sept 2026

Hover or tap the chart for the NAV on any date. Past NAVs are adjusted for unit splits.

If you had invested in this fund

Investment type
years
Total invested
₹1,80,000
Gain
₹53,368
XIRR (per year)
17.67%
Value today
₹2,33,368

36 monthly instalments from 22 Sept 2023, valued at the latest NAV. Past returns do not guarantee future returns.

What the ride has been like

Worked out from this fund's own NAV history, not a rating.

How bumpy
12.9% a year
2.7% less than the category average — the steadier side
Worst fall so far
−20.5%
Sept 2021 to Jun 2022, against −25.3% for the category.
Years that made money
80%
Of every one-year stretch it has been through.
Over any three years
12.1% to 27.8%
A year, at worst and at best. Typically 19.6%.

Fund details

Minimum lumpsum
₹1,000
Minimum top-up
₹1,000
Lock-in
None
Plan started
11 Jul 2019
Portfolio turnover
0.19x
Expense ratio
0.8%
as of 31 Jul 2026

Managed by Dhaval Shah

Direct plan figures, last checked on 20 Sept 2026. Exit load and the scheme's benchmark are in thescheme document.

How it compares

Aditya Birla Sun Life Pharma and Healthcare Fund against other funds in the Sectoral / Thematic Fund category
Fund1Y3Y5YExpenseFund size
Nippon India Taiwan Equity Fund118%61.43%1.24%₹1,128 Cr
HDFC Defence Fund21.09%37.07%0.9%₹11,478 Cr
HDFC Transportation and Logistics Fund7.35%24.8%1.09%₹2,116 Cr
SBI Healthcare Opportunities Fund20.88%24.31%18.52%1.02%₹5,796 Cr
UTI - Healthcare Fund16.82%24.15%16.09%1.28%₹1,444 Cr
LIC MF Infrastructure Fund8.97%23.9%21.88%1.35%₹1,174 Cr
Aditya Birla Sun Life Pharma and Healthcare Fund17.58%21.57%14.47%0.8%₹1,103 Cr

About Aditya Birla Sun Life Pharma and Healthcare Fund

Aditya Birla Sun Life Pharma and Healthcare Fund is a sectoral / thematic fund managed by Aditya Birla Sun Life Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.

The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.

The scheme's stated objective, as published by Aditya Birla Sun Life Mutual Fund.

The NAV (net asset value) is the price of one unit of the fund. It is published by the fund house every business day and changes with the value of the fund's holdings. The Growth option reinvests all gains, so its NAV reflects the fund's total return.

Tax on your gains

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Work out what you would owe with the capital gains tax calculator.

Every plan and option, with scheme codes
PlanOptionNAVScheme code
DirectGROWTH₹40.80147409
DirectIDCW₹26.53147410
RegularGrowth₹36.60147407
RegularIDCW₹24.17147408

Frequently asked questions

What is the NAV of Aditya Birla Sun Life Pharma and Healthcare Fund today?

The NAV of Aditya Birla Sun Life Pharma and Healthcare Fund (Direct plan, Growth) is ₹40.80 and the Regular plan NAV is ₹36.60, as of 18 Sept 2026.

What returns has Aditya Birla Sun Life Pharma and Healthcare Fund given?

Over the last year the Direct plan returned 17.58%, and 21.57% a year over 3 years and 14.47% a year over 5 years. That places it 14 of 136 funds in its category over 3 years. Past returns do not guarantee future returns.

What is the expense ratio of Aditya Birla Sun Life Pharma and Healthcare Fund?

The Direct plan charges 0.8% a year, as disclosed on 31 Jul 2026. The fee is already taken out of the NAV, so the returns above are what you keep.

What is the minimum SIP amount in Aditya Birla Sun Life Pharma and Healthcare Fund?

You can start a monthly SIP with ₹100, or invest a lump sum of ₹1,000 or more.

How much has Aditya Birla Sun Life Pharma and Healthcare Fund fallen in the past?

Its deepest fall was 20.5% from 16 Sept 2021 to 17 Jun 2022. Of every one-year stretch in its history, 80% ended in a gain.

Which category does Aditya Birla Sun Life Pharma and Healthcare Fund belong to?

It is a Sectoral / Thematic Fund from Aditya Birla Sun Life Mutual Fund. Invest in one sector (such as banking, IT or pharma) or a theme (such as consumption or infrastructure). Concentrated and higher risk; suited to investors with a view on that sector.

What is the difference between the Direct and Regular plan?

Both invest in the same portfolio. The Direct plan is bought straight from the fund house or a direct platform and has a lower expense ratio because no distributor commission is paid, so its NAV grows slightly faster over time.

How are gains from Aditya Birla Sun Life Pharma and Healthcare Fund taxed?

Gains are taxed as equity: sell within 12 months and the gain is short-term, taxed at 20%. Hold longer and it is long-term, taxed at 12.5% on gains above ₹1.25 lakh in a financial year, across all your equity investments.

Source: NAVs published by the fund house through AMFI. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not guarantee future returns. This page is for information only and is not a recommendation to buy or sell.